Photo from
LUNGevity Foundation/X
Aug 22, 2024, 14:04
“What do LUNGevity’s Research Awards mean to you” with Dr. Alexandre Reuben
LUNGevity Foundation shared a post on X:
” ‘By working with the patient-led advocacy groups, it’s an opportunity for me to make sure that the work we are doing in the lab has a direct impact on patient outcomes.’
Proceed to the video attached to the post.
Source: LUNGevity Foundation/X
More posts by LUNGevity Foundation on OncoDaily.
Dr. Alexandre Reuben is an Assistant Professor at MD Anderson Cancer Center and Co-Director of the Immunology Program at UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences. He is the Founder of Tenaci-T Therapeutics. His research focuses on enhancing the immune response against lung tumors.